Process to prepare treprostinil, the active ingredient in remodulin®
US-2015376106-A1 · Dec 31, 2015 · US
US9527800B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9527800-B2 |
| Application number | US-201415033506-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 29, 2014 |
| Priority date | Oct 29, 2013 |
| Publication date | Dec 27, 2016 |
| Grant date | Dec 27, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
There is a need for short, resolution free asymmetric process for synthesis of one isomer of venlafaxine, (−)-venlafaxine. The invention provides a novel, short process of synthesis of (−)-venlafaxine, with yield greater than 50% and ee>99%. This process can be used for racemic synthesis of venlafaxine with overall yield 65%.
Opening claim text (preview).
We claim: 1. A process for the synthesis of venlafaxine of formula 1 or its enantiomer, wherein the process comprising the steps: a. homologating carbonyl of cyclohexanone with two carbon Wittig ylide with heating at 50° C. to 140° C. in toluene to obtain α, β-unsaturated ester; b. subjecting the ester of step (a) to selective ester reduction by Red-Al to give allyl alcohol; c. subjecting allyl alcohol of step (b) for epoxidation reaction to afford epoxide; d. treating the epoxide of step (c) with methane sulphonyl chloride and triethyl amine to obtain crude mesylate, which on subsequently subjecting for amination in 40% aqueous dimethyl amine solution at room temperature to affords the epoxy amine; and e. treating epoxy amine of step (d) with p-methoxyphenyl magnesium bromide in presence of catalytic copper iodide to furnish venlafaxine. 2. The process according to claim 1 wherein the epoxidation in step (c) is carried out by the method selected from a group consisting of Sharpless epoxidation or by mCPBA in presence of NaHCO 3 to produce chiral or racemic epoxide respectively. 3. The process according to claim 1 , step (a), wherein the temperature is ranging between 50-140° C. and reflux time is ranging between 20-24 h. 4. The process according to claim 1 , step (b), wherein the temperature is 0° C. and stirring time is 10 to 30 mins. 5. The process according to claim 1 , step (c), wherein the temperature is in the range of 20 to 35° C. and stirring time is 6-8 h. 6. The process according to claim 1 , step (d), wherein the epoxidation is carried out at temperature in the range of 0° C. to 60° C. and stirring time is ranging between 10-12 h. 7. The process according to claim 1 wherein Sharpless asymmetric epoxidation for synthesis of asymmetric venlafaxine is carried out at a temperature ranging between −20 to −50° C. to obtain chiral epoxide. 8. The process according to claim 1 , step (e), wherein the temperature is −30-to-40° C. and stirring for a period ranging between 4-5 h. 9. The process according to claim 1 , wherein the yield is preferably 53% with ee>99%. 10. The process according to claim 1 , wherein the yield is preferably >64% for racemic venlafaxine ((±)-venlafaxine).
by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups · CPC title
by oxidation of secondary alcohols or ketones · CPC title
of carboxylic acids or derivatives thereof · CPC title
Chemistry & Metallurgy · mapped topic
Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.